Report of Foreign Issuer (6-k)
09 September 2019 - 9:12PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
Form 6-K
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO RULE 13a-16 OR 15d-16 UNDER
THE
SECURITIES EXCHANGE ACT OF 1934
For
the month of September 2019
Commission
File Number 001-38370
CollPlant
Biotechnologies Ltd.
(Exact
name of registrant as specified in its charter)
4
Oppenheimer, Weizmann Science Park
Rehovot
7670104, Israel
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(1): ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(7): ☐
The first sentence of the first
paragraph and “Forward Looking Statements” of the press release attached to this Form 6-K are hereby incorporated
by reference into the registrant’s Registration Statements on Form S-8 (File No. 333-229163)
and Form F-3 (File No. 333-229486
and 333-228054),
to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports
subsequently filed or furnished.
CollPlant
Biotechnologies Ltd. (the “Company”) has posted to its website an updated corporate presentation. A copy of the presentation
is furnished with this Report of Foreign Private Issuer on Form 6-K as Exhibit 99.1
and is incorporated herein by reference.
Attached hereto as Exhibit 99.2 and incorporated by reference herein is a press
release issued by the Company entitled “CollPlant Biotechnologies Closes on $5.5 Million Financing.”
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
COLLPLANT
BIOTECHNOLOGIES LTD.
|
|
|
|
Date:
September 9, 2019
|
By:
|
/s/
Eran Rotem
|
|
|
Name:
Eran Rotem
|
|
|
Title:
Deputy CEO and Chief Financial Officer
|
2
CollPlant Biotechnologies (NASDAQ:CLGN)
Historical Stock Chart
From Mar 2024 to May 2024
CollPlant Biotechnologies (NASDAQ:CLGN)
Historical Stock Chart
From May 2023 to May 2024